Washington Trust’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12
Closed -$863 920
2023
Q1
$863 Hold
12
﹤0.01% 903
2022
Q4
$895 Sell
12
-5
-29% -$358 ﹤0.01% 914
2022
Q3
$1K Hold
17
﹤0.01% 847
2022
Q2
$1K Sell
17
-4
-19% -$322 ﹤0.01% 850
2022
Q1
$2K Hold
21
﹤0.01% 814
2021
Q4
$2K Buy
21
+6
+40% +$612 ﹤0.01% 819
2021
Q3
$1K Sell
15
-2
-12% -$202 ﹤0.01% 1005
2021
Q2
$2K Buy
+17
New +$1.73K ﹤0.01% 934

Other funds holding CRI

Washington Trust's CRI Position: Q2 2023 in Review

Washington Trust sold out of Carter's (CRI) in Q2 2023, closing a stake of 12 shares — an estimated $863 sold.

Washington Trust first reported a position in CRI in Q2 2021 and held it in 8 quarters. The position peaked at $2K in Q1 2022. 292 funds tracked by Wall St. Rank hold CRI as of Q2 2023.

  • Washington Trust reported no remaining Carter's position as of Q2 2023 after selling out during the quarter.
  • Washington Trust sold 12 Carter's shares in Q2 2023, an estimated $863.
  • Washington Trust first reported a position in Carter's in Q2 2021 and held it in 8 quarters.
  • Washington Trust's Carter's position peaked at $2K in Q1 2022.
  • 292 funds tracked by Wall St. Rank held Carter's as of Q2 2023.

Based on Washington Trust's 13F filing for Q2 2023, filed 27 Jul 2023.